Pengfei Liu

机构：Sinopec (China), Beijing Institute of Technology, Fujian Medical University, Shandong University of Traditional Chinese Medicine, Central South University, National University of Defense Technology, Xuzhou Medical College, Capital Medical University, Nanjing University of Posts and Telecommunications, Jiangyin People's Hospital, Protein Technologies (United Kingdom), First Affiliated Hospital of Fujian Medical University, The First People's Hospital of Changde, Beijing Shijitan Hospital · ORCID：0000-0002-2971-3800

发表论文 115 篇 · 总被引 1526 次 · h-index 19

代表论文

Methylmalonic acid promotes colorectal cancer progression via activation of Wnt/β-catenin pathway mediated epithelial–mesenchymal transition (2023 · Cancer Cell International · 被引 20)
Advancements in Bacteriophages for the Fire Blight Pathogen Erwinia amylovora (2024 · Viruses · 被引 16)
Application of linaclotide in bowel preparation for colonoscopy in patients with constipation: A prospective randomized controlled study (2024 · Journal of Gastroenterology and Hepatology · 被引 16)
Few-Shot Domain Adaption-Based Specific Emitter Identification Under Varying Modulation (2023 · 被引 15)
FOXA2-initiated transcriptional activation of INHBA induced by methylmalonic acid promotes pancreatic neuroendocrine neoplasm progression (2024 · Cellular and Molecular Life Sciences · 被引 9)
Comprehensive multi-omics analyses expose a precision therapy strategy that targets replication stress in hepatocellular carcinoma using WEE1 inhibition (2025 · Journal of Advanced Research · 被引 8)